Does SIROLIMUS Cause Bladder transitional cell carcinoma? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Bladder transitional cell carcinoma have been filed in association with SIROLIMUS (sirolimus). This represents 0.2% of all adverse event reports for SIROLIMUS.
17
Reports of Bladder transitional cell carcinoma with SIROLIMUS
0.2%
of all SIROLIMUS reports
0
Deaths
0
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From SIROLIMUS?
Of the 17 reports.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIROLIMUS. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does SIROLIMUS Cause?
Off label use (1,960)
Drug ineffective (1,005)
Product use in unapproved indication (984)
Transplant rejection (698)
Pneumonia (599)
Product use issue (506)
Alopecia (491)
Acne (482)
Transplant dysfunction (468)
Condition aggravated (433)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which SIROLIMUS Alternatives Have Lower Bladder transitional cell carcinoma Risk?
SIROLIMUS vs SIRUKUMAB
SIROLIMUS vs SITAGLIPTIN
SIROLIMUS vs SOAP
SIROLIMUS vs SODIUM
SIROLIMUS vs SODIUM BICARBONATE